Last 7 days
-5.0%
Last 30 days
-13.0%
Last 90 days
-20.9%
Trailing 12 Months
-25.8%
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
UNH | 440.9B | 324.2B | -6.04% | -5.61% | 21.91 | 1.36 | 12.71% | 16.40% |
CI | 91.1B | 180.5B | -9.45% | 16.50% | 13.64 | 1.92 | 3.70% | 24.58% |
HUM | 62.6B | 92.9B | -3.60% | 10.39% | 22.31 | 0.67 | 11.81% | -4.33% |
CNC | 34.8B | 144.5B | -13.05% | -25.78% | 28.95 | 0.24 | 14.74% | -10.76% |
MID-CAP | ||||||||
LHCG | 5.2B | 2.3B | 3.17% | 35.63% | 86.23 | 2.28 | 2.85% | -58.05% |
HQY | 5.0B | 831.2M | -11.67% | 3.11% | -84.99 | 6.01 | 12.11% | -862.52% |
AMN | 3.6B | 5.2B | -10.88% | -15.90% | 8.03 | 0.68 | 31.60% | 35.63% |
CRVL | 3.2B | 704.5M | -0.70% | 13.53% | 47.24 | 4.55 | 13.56% | 10.15% |
PDCO | 2.5B | 6.4B | -14.06% | -14.67% | 12.88 | 0.39 | -0.52% | 17.01% |
SMALL-CAP | ||||||||
TVTY | 1.6B | - | 0.59% | 17.88% | 18.77 | 3.24 | - | - |
ADUS | 1.6B | 951.1M | -7.28% | 30.41% | 34.53 | 1.67 | 10.02% | 1.99% |
RDNT | 1.3B | 1.4B | 12.22% | 10.36% | 120.12 | 0.89 | 8.74% | -56.93% |
BKD | 524.3M | 2.8B | -3.12% | -59.80% | -2.2 | 0.19 | 2.43% | -140.13% |
Income Statement (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Revenue | 2.1% | 144,547 | 141,554 | 138,095 | 133,184 | 125,982 |
S&GA Expenses | 4.6% | 11,589 | 11,082 | 10,773 | 10,112 | 9,601 |
Costs and Expenses | 2.8% | 143,229 | 139,351 | 135,823 | 131,201 | 124,198 |
EBITDA | -3.9% | 4,180 | 4,350 | 4,059 | 3,958 | - |
EBITDA Margin | -5.9% | 0.03* | 0.03* | 0.03* | 0.03* | - |
Earnings Before Taxes | -25.0% | 1,962 | 2,615 | 2,326 | 2,020 | 1,813 |
EBT Margin | -26.5% | 0.01* | 0.02* | 0.02* | 0.02* | - |
Interest Expenses | 1.8% | 665 | 653 | 654 | 655 | 665 |
Net Income | -40.3% | 1,202 | 2,014 | 1,860 | 1,497 | 1,347 |
Net Income Margin | -41.6% | 0.01* | 0.01* | 0.01* | 0.01* | - |
Free Cahsflow | -29.8% | 5,257 | 7,493 | 5,985 | 4,348 | - |
Balance Sheet | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Assets | -5.3% | 76,870 | 81,172 | 81,060 | 82,901 | 78,375 |
Current Assets | -9.5% | 30,128 | 33,275 | 32,406 | 31,110 | 28,497 |
Cash Equivalents | -19.4% | 12,074 | 14,987 | 13,435 | 11,237 | 13,118 |
Net PPE | -1.9% | 2,432 | 2,479 | 2,557 | 3,583 | 3,391 |
Goodwill | -6.1% | 18,812 | 20,040 | 20,310 | 20,903 | 19,771 |
Liabilities | -5.3% | 52,633 | 55,572 | 54,497 | 55,471 | 51,353 |
Current Liabilities | -9.1% | 28,464 | 31,330 | 29,086 | 29,685 | 25,765 |
Long Term Debt | - | 19,026 | - | - | - | - |
LT Debt, Current | -67.1% | 82.00 | 249 | 300 | 292 | 267 |
LT Debt, Non Current | -0.8% | 17,938 | 18,084 | 18,456 | 18,640 | 18,571 |
Shareholder's Equity | -5.2% | 24,057 | 25,378 | 26,430 | 27,313 | 26,795 |
Retained Earnings | -2.2% | 9,341 | 9,554 | 8,816 | 8,988 | 8,139 |
Additional Paid-In Capital | 1.4% | 20,060 | 19,774 | 19,899 | 19,830 | 19,672 |
Shares Outstanding | -3.4% | 551 | 570 | 581 | 585 | 582 |
Minority Interest | -20.5% | 124 | 156 | 141 | 144 | 145 |
Cashflow (Last 12 Months) | (In Millions) | |||||
---|---|---|---|---|---|---|
Description | (%) Q/Q | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 |
Cashflow From Operations | -26.4% | 6,261 | 8,512 | 6,982 | 5,313 | 4,205 |
Share Based Compensation | -8.6% | 234 | 256 | 245 | 222 | 203 |
Cashflow From Investing | 27.0% | -2,921 | -3,999 | -5,024 | -5,093 | -3,299 |
Cashflow From Financing | -55.4% | -4,197 | -2,700 | 424 | 937 | 1,362 |
Buy Backs | 62.0% | 3,096 | 1,911 | 684 | 339 | 297 |
56.9%
17.7%
0%
Y-axis is the maximum loss one would have experienced if Centene was unfortunately bought at previous high price.
18.7%
11.8%
3.8%
0.0%
FIve years rolling returns for Centene.
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
2023-03-15 | B. Riley Wealth Advisors, Inc. | added | 2.2 | 32,087 | 449,087 | 0.01% |
2023-03-10 | VICTORY CAPITAL MANAGEMENT INC | added | 1.37 | 8,920,250 | 139,262,000 | 0.15% |
2023-03-10 | MATHER GROUP, LLC. | added | 5.35 | 83,021 | 832,021 | 0.02% |
2023-03-07 | Great Lakes Retirement, Inc. | new | - | 475,592 | 475,592 | 0.12% |
2023-03-06 | Aldebaran Financial Inc. | reduced | -5.05 | -25,593 | 1,188,410 | 1.28% |
2023-03-06 | Rockefeller Capital Management L.P. | reduced | -38.2 | -48,627,000 | 90,830,000 | 0.46% |
2023-03-03 | TIAA, FSB | reduced | -13.26 | -44,816 | 479,184 | -% |
2023-03-02 | OLIVER LAGORE VANVALIN INVESTMENT GROUP | reduced | -49.43 | -6,701 | 7,299 | -% |
2023-02-28 | Voya Investment Management LLC | reduced | -7.91 | -963,960 | 31,815,000 | 0.04% |
2023-02-24 | NATIXIS | reduced | -12.8 | -618,037 | 6,400,960 | 0.04% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 13, 2023 | capital world investors | 8.8% | 49,809,061 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 11.52% | 65,260,984 | SC 13G/A | |
Jan 31, 2023 | blackrock inc. | 7.2% | 40,669,044 | SC 13G/A | |
Feb 14, 2022 | price t rowe associates inc /md/ | 4.9% | 28,709,382 | SC 13G/A | |
Feb 11, 2022 | capital world investors | 8.0% | 46,851,859 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 10.71% | 62,485,541 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G/A | |
Feb 03, 2022 | blackrock inc. | 7.1% | 41,158,173 | SC 13G/A | |
Feb 16, 2021 | capital world investors | 6.5% | 37,874,670 | SC 13G/A |
Fair Value | Very Pessimistic | Pessimistic | Base Case | Optimistic | Very Optimistic |
---|---|---|---|---|---|
Very Low Inflation | 115.05 82.07% | 160.16 153.46% | 232.02 267.18% | 367.66 481.83% | 519.30 721.81% |
Current Inflation | 104.74 65.75% | 143.10 126.46% | 203.46 221.98% | 318.19 403.54% | 446.78 607.04% |
Very High Inflation | 92.15 45.83% | 122.74 94.24% | 170.11 169.20% | 261.23 313.40% | 363.80 475.72% |
Date Filed | Form Type | Document | |
---|---|---|---|
Mar 14, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 06, 2023 | 4 | Insider Trading | |
Mar 02, 2023 | 4 | Insider Trading | |
Feb 21, 2023 | 10-K | Annual Report | |
Feb 21, 2023 | 4 | Insider Trading | |
Feb 14, 2023 | 5 | Insider Trading | |
Feb 13, 2023 | SC 13G/A | Major Ownership Report | |
Feb 10, 2023 | 4 | Insider Trading | |
Feb 09, 2023 | SC 13G/A | Major Ownership Report |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
2023-03-02 | Asher Andrew Lynn | sold (taxes) | -152,572 | 68.51 | -2,227 | evp, cfo |
2023-02-28 | LONDON SARAH | sold (taxes) | -176,837 | 70.09 | -2,523 | chief executive officer |
2023-02-10 | Asher Andrew Lynn | bought | 273,486 | 71.97 | 3,800 | evp, cfo |
2023-02-09 | Asher Andrew Lynn | bought | 215,670 | 71.89 | 3,000 | evp, cfo |
2023-02-08 | Samuels Theodore R. II | bought | 503,160 | 71.88 | 7,000 | - |
2023-02-08 | MURRAY JAMES E | bought | 494,775 | 73.3 | 6,750 | evp, chief operating officer |
2023-02-07 | Burdick Kenneth A | acquired | - | - | 1,901 | - |
2023-02-07 | Asher Andrew Lynn | acquired | - | - | 611 | evp, cfo |
2023-02-07 | Asher Andrew Lynn | sold (taxes) | -730,480 | 71.01 | -10,287 | evp, cfo |
2023-02-07 | KOSTER CHRISTOPHER | acquired | - | - | 324 | evp, secr. & general counsel |
CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Millions | 12 Months Ended | ||
---|---|---|---|
Dec. 31, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Revenues: | |||
Revenues | $ 135,479 | $ 117,983 | $ 103,800 |
Premium tax and health insurer fee | 9,068 | 7,999 | 7,315 |
Total revenues | 144,547 | 125,982 | 111,115 |
Expenses: | |||
Medical costs | 111,529 | 98,602 | 86,264 |
Cost of services | 7,032 | 4,894 | 3,303 |
Selling, general and administrative expenses | 11,589 | 9,601 | 9,380 |
Depreciation expense | 614 | 565 | 487 |
Amortization of acquired intangible assets | 817 | 770 | 719 |
Premium tax expense | 9,330 | 8,287 | 6,332 |
Health insurer fee expense | 0 | 0 | 1,476 |
Impairment | 2,318 | 229 | 72 |
Legal settlement | 0 | 1,250 | 0 |
Total operating expenses | 143,229 | 124,198 | 108,033 |
Earnings from operations | 1,318 | 1,784 | 3,082 |
Other income (expense): | |||
Investment and other income | 1,279 | 819 | 480 |
Debt extinguishment | 30 | (125) | (61) |
Interest expense | (665) | (665) | (728) |
Earnings before income tax | 1,962 | 1,813 | 2,773 |
Income tax expense | 760 | 477 | 979 |
Net earnings | 1,202 | 1,336 | 1,794 |
Loss attributable to noncontrolling interests | 0 | 11 | 14 |
Net earnings attributable to Centene Corporation | $ 1,202 | $ 1,347 | $ 1,808 |
Net earnings per common share attributable to Centene Corporation: | |||
Basic earnings per common share (in usd per share) | $ 2.09 | $ 2.31 | $ 3.17 |
Diluted earnings per common share (in usd per share) | $ 2.07 | $ 2.28 | $ 3.12 |
Weighted average number of common shares outstanding: | |||
Basic (in shares) | 575,191 | 582,832 | 570,722 |
Diluted (in shares) | 582,040 | 590,516 | 579,135 |
Premium | |||
Revenues: | |||
Revenues | $ 127,131 | $ 112,319 | $ 100,055 |
Service | |||
Revenues: | |||
Revenues | $ 8,348 | $ 5,664 | $ 3,745 |
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions | Dec. 31, 2022 | Dec. 31, 2021 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 12,074 | $ 13,118 |
Premium and trade receivables | 13,272 | 12,238 |
Short-term investments | 2,321 | 1,539 |
Other current assets | 2,461 | 1,602 |
Total current assets | 30,128 | 28,497 |
Long-term investments | 14,684 | 14,043 |
Restricted deposits | 1,217 | 1,068 |
Property, software and equipment, net | 2,432 | 3,391 |
Goodwill | 18,812 | 19,771 |
Intangible assets, net | 6,911 | 7,824 |
Other long-term assets | 2,686 | 3,781 |
Total assets | 76,870 | 78,375 |
Current liabilities: | ||
Medical claims liability | 16,745 | 14,243 |
Accounts payable and accrued expenses | 9,525 | 8,493 |
Return of premium payable | 1,634 | 2,328 |
Unearned revenue | 478 | 434 |
Current portion of long-term debt | 82 | 267 |
Total current liabilities | 28,464 | 25,765 |
Long-term debt | 17,938 | 18,571 |
Deferred tax liability | 615 | 1,407 |
Other long-term liabilities | 5,616 | 5,610 |
Total liabilities | 52,633 | 51,353 |
Commitments and contingencies | ||
Redeemable noncontrolling interests | 56 | 82 |
Stockholders' equity: | ||
Preferred stock, $0.001 par value; authorized 10,000 shares; no shares issued or outstanding at December 31, 2022 and December 31, 2021 | 0 | 0 |
Common stock, $0.001 par value; authorized 800,000 shares; 607,847 issued and 550,754 outstanding at December 31, 2022, and 602,704 issued and 582,479 outstanding at December 31, 2021 | 1 | 1 |
Additional paid-in capital | 20,060 | 19,672 |
Accumulated other comprehensive earnings (loss) | (1,132) | 77 |
Retained earnings | 9,341 | 8,139 |
Treasury stock, at cost (57,093 and 20,225 shares, respectively) | (4,213) | (1,094) |
Total Centene stockholders' equity | 24,057 | 26,795 |
Nonredeemable noncontrolling interest | 124 | 145 |
Total stockholders' equity | 24,181 | 26,940 |
Total liabilities, redeemable noncontrolling interests and stockholders' equity | $ 76,870 | $ 78,375 |